105 related articles for article (PubMed ID: 23040864)
1. Lasp1 is down-regulated in NMDA receptor antagonist-treated mice and implicated in human schizophrenia susceptibility.
Joo J; Lee S; Nah SS; Kim YO; Kim DS; Shim SH; Hwangbo Y; Kim HK; Kwon JT; Kim JW; Song HY; Kim HJ
J Psychiatr Res; 2013 Jan; 47(1):105-12. PubMed ID: 23040864
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism in the LASP1 gene promoter region alters cognitive functions of patients with schizophrenia.
Lin CH; Yang S; Huang YJ; Lane HY
Sci Rep; 2019 Dec; 9(1):18840. PubMed ID: 31827227
[TBL] [Abstract][Full Text] [Related]
3. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.
Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Uchida Y; Kawahara K; Nishiyama K; Seki N; Nakagawa M
Urol Oncol; 2012; 30(4):434-43. PubMed ID: 20843712
[TBL] [Abstract][Full Text] [Related]
4. Suppression of LIM and SH3 Domain Protein 1 (LASP1) Negatively Regulated by Androgen Receptor Delays Castration Resistant Prostate Cancer Progression.
Dejima T; Imada K; Takeuchi A; Shiota M; Leong J; Tombe T; Tam K; Fazli L; Naito S; Gleave ME; Ong CJ
Prostate; 2017 Feb; 77(3):309-320. PubMed ID: 27775154
[TBL] [Abstract][Full Text] [Related]
5. LASP1 is a HIF1α target gene critical for metastasis of pancreatic cancer.
Zhao T; Ren H; Li J; Chen J; Zhang H; Xin W; Sun Y; Sun L; Yang Y; Sun J; Wang X; Gao S; Huang C; Zhang H; Yang S; Hao J
Cancer Res; 2015 Jan; 75(1):111-9. PubMed ID: 25385028
[TBL] [Abstract][Full Text] [Related]
6. Endometrial stromal cell proteomic analysis reveals LIM and SH3 protein 1 (LASP1) plays important roles in the progression of adenomyosis.
Liu F; Li Z; Guo J; Fang S; Zhou J; Cao B; Liu J; Yi Y; Yuan X; Xu X; Huang O; Wang L; Zou Y
Mol Hum Reprod; 2021 Feb; 27(3):. PubMed ID: 33543750
[TBL] [Abstract][Full Text] [Related]
7. LIM and SH3 protein 1 (Lasp1) is a novel p53 transcriptional target involved in hepatocellular carcinoma.
Wang B; Feng P; Xiao Z; Ren EC
J Hepatol; 2009 Mar; 50(3):528-37. PubMed ID: 19155088
[TBL] [Abstract][Full Text] [Related]
8. miR-203 inhibits the migration and invasion of esophageal squamous cell carcinoma by regulating LASP1.
Takeshita N; Mori M; Kano M; Hoshino I; Akutsu Y; Hanari N; Yoneyama Y; Ikeda N; Isozaki Y; Maruyama T; Akanuma N; Miyazawa Y; Matsubara H
Int J Oncol; 2012 Nov; 41(5):1653-61. PubMed ID: 22940702
[TBL] [Abstract][Full Text] [Related]
9. Expression of NR1, NR2A and NR2B NMDA receptor subunits is not altered in the genetically-inbred Balb/c mouse strain with heightened behavioral sensitivity to MK-801, a noncompetitive NMDA receptor antagonist.
Perera PY; Lichy JH; Mastropaolo J; Rosse RB; Deutsch SI
Eur Neuropsychopharmacol; 2008 Nov; 18(11):814-9. PubMed ID: 18674888
[TBL] [Abstract][Full Text] [Related]
10. Regulation of matrix metalloproteinases (MMPs) expression and secretion in MDA-MB-231 breast cancer cells by LIM and SH3 protein 1 (LASP1).
Endres M; Kneitz S; Orth MF; Perera RK; Zernecke A; Butt E
Oncotarget; 2016 Sep; 7(39):64244-64259. PubMed ID: 27588391
[TBL] [Abstract][Full Text] [Related]
11. LIM and SH3 protein 1 regulates cell growth and chemosensitivity of human glioblastoma via the PI3K/AKT pathway.
Zhong C; Chen Y; Tao B; Peng L; Peng T; Yang X; Xia X; Chen L
BMC Cancer; 2018 Jul; 18(1):722. PubMed ID: 29980193
[TBL] [Abstract][Full Text] [Related]
12. Role of LIM and SH3 protein 1 (LASP1) in the metastatic dissemination of medulloblastoma.
Traenka C; Remke M; Korshunov A; Bender S; Hielscher T; Northcott PA; Witt H; Ryzhova M; Felsberg J; Benner A; Riester S; Scheurlen W; Grunewald TG; von Deimling A; Kulozik AE; Reifenberger G; Taylor MD; Lichter P; Butt E; Pfister SM
Cancer Res; 2010 Oct; 70(20):8003-14. PubMed ID: 20924110
[TBL] [Abstract][Full Text] [Related]
13. LASP1 in Tumor and Tumor Microenvironment.
Hu Z; Wang X; Cui Y; Li C; Wang S
Curr Mol Med; 2017; 17(8):541-548. PubMed ID: 29473505
[TBL] [Abstract][Full Text] [Related]
14. An update on the LIM and SH3 domain protein 1 (LASP1): a versatile structural, signaling, and biomarker protein.
Orth MF; Cazes A; Butt E; Grunewald TG
Oncotarget; 2015 Jan; 6(1):26-42. PubMed ID: 25622104
[TBL] [Abstract][Full Text] [Related]
15. LASP1 in Cellular Signaling and Gene Expression: More than Just a Cytoskeletal Regulator.
Butt E; Howard CM; Raman D
Cells; 2022 Nov; 11(23):. PubMed ID: 36497077
[TBL] [Abstract][Full Text] [Related]
16. Long-term behavioral and NMDA receptor effects of young-adult corticosterone treatment in BDNF heterozygous mice.
Klug M; Hill RA; Choy KH; Kyrios M; Hannan AJ; van den Buuse M
Neurobiol Dis; 2012 Jun; 46(3):722-31. PubMed ID: 22426399
[TBL] [Abstract][Full Text] [Related]
17. LIM and SH3 protein 1, a promoter of cell proliferation and migration, is a novel independent prognostic indicator in hepatocellular carcinoma.
Wang H; Li W; Jin X; Cui S; Zhao L
Eur J Cancer; 2013 Mar; 49(4):974-83. PubMed ID: 23084841
[TBL] [Abstract][Full Text] [Related]
18. Early postnatal depletion of NMDA receptor development affects behaviour and NMDA receptor expression until later adulthood in rats--a possible model for schizophrenia.
Baier PC; Blume A; Koch J; Marx A; Fritzer G; Aldenhoff JB; Schiffelholz T
Behav Brain Res; 2009 Dec; 205(1):96-101. PubMed ID: 19539658
[TBL] [Abstract][Full Text] [Related]
19. Effects on rat thalamic proteome by acute and subchronic MK-801-treatment.
Paulson L; Martin P; Ljung E; Blennow K; Davidsson P
Eur J Pharmacol; 2004 Nov; 505(1-3):103-9. PubMed ID: 15556142
[TBL] [Abstract][Full Text] [Related]
20. Loss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1 (LASP1) in high-risk prostate cancer thereby increasing cell proliferation and migration.
Hailer A; Grunewald TG; Orth M; Reiss C; Kneitz B; Spahn M; Butt E
Oncotarget; 2014 Jun; 5(12):4144-4153. PubMed ID: 24980827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
